期刊文献+

慢性肝病肝剪切波速与血清肝纤维化标志物在肝纤维化诊断中的对比研究 被引量:3

Comparative study between liver shear wave velocity and serum liver fibrosis markers in diagnosis of liver fibrosis in chronic hepatic diseases
下载PDF
导出
摘要 目的探讨慢性肝病肝剪切波速及血清肝纤维化标志物在肝纤维化分级诊断中的临床应用价值。方法选择235例慢性肝病患者(肝纤维化组),其中男性179例,女性56例;年龄17-64岁,平均年龄36.3岁。40例健康对照者,其中男性25例,女性15例;年龄25-62岁,平均年龄43.2岁。先进行肝剪切波速和抽血实验室检查,然后在超声引导下穿刺活组织检查,以病理结果为标准,分析剪切波速及血清肝纤维化标志物在评价肝纤维化分级之间的关系。并将检查结果与健康对照者进行比较。结果235例慢性肝病患者有215例进行肝穿刺活组织检查,除F0级肝病患者与健康对照组F0级之间剪切波速比较差异无统计学意义(P〉0.05)外,其余肝病各分组剪切波速随肝纤维化程度的增高而波速增快;且血清肝纤维化标志物含量亦随肝纤维化病理分期的增高而增高。结论肝剪切波速及血清肝纤维化标志物对肝纤维化患者的病理分期有良好相关性,对肝纤维化的诊断及疗效观察有重要的临床应用价值。 Objective To explore clinical value of liver shear wave velocity and serum fibrosis markers in chronic hepatic diseases for the grading diaguosis of liver fibrosis. Methods A total of 235 patients with chronic hepatitis were enrolled, male 179, female 56, aged 17 - 64 years old, mean age 36.3 years old. Forty healthy people were as the control, male 25, female 15, aged 25 - 62 years old, mean age 43.2 years old. All of them performed liver shear wave velocity and blood laboratory tests, and then carried out liver biopsy under ultrasound-guided. The pathologic finding was as the standard. The relationship between shear wave velocity and serum liver fibrosis markers for liver fibrosis grading was analyzed, and the test results were compared with the healthy controls. Results The 215 of 235 patients were underwent percutaneous liver biopsy. The liver shear wave velocity showed no significant difference between F0 and healthy control group. In other groups, both shear wave velocity and the content of serum liver fibrosis markers increased with the degree of liver fibrosis. Conclusion It is demonstrated that both shear wave velocity and serum liver fibrosis markers are very correlated with pathologic stage of liver fibrosis, and which has important clinical value for the diaznosis and curative effects of hepatic fibrosis.
出处 《生物医学工程与临床》 CAS 2012年第5期458-461,共4页 Biomedical Engineering and Clinical Medicine
关键词 肝纤维化 剪切波速 血清肝纤维化标志物 病理分期 liver fibrosis shear-wave speed fibrosis marker in serum pathologic stage
  • 相关文献

参考文献14

  • 1王红英.门静脉血流动力学及脾脏大小与肝纤维化关系[J].临床医学工程,2009,16(11):50-51. 被引量:3
  • 2Yeshua H, Oren R. Non invasive assessment of liver fibrosis[J]. Ann Transplant, 2008, 13(2): 5-11.
  • 3Ziol M, Handra-Luca A, Kettaneh A, et aL Noninvasive asses- sment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C[J]. Hepatology, 2005, 41 (1): 48- 54.
  • 4Koinuma M, Ohashi I, Hanafusa K, et al. Apparent diffusion coe- fficient measurements with diffusion-weighted magnetic reson- ance imaging for evaluation of hepatic fibrosis[J]. J Magn Reson Imaging, 2005, 22(1): 80-85.
  • 5孙德胜,孟繁坤,王金锐,邵金华,崔立刚.慢性肝病肝剪切波速与纤维化分级的相关性研究[J].中国医学影像学杂志,2009,17(4):241-245. 被引量:69
  • 6杨一林,迪丽,段云友,刘杰,陈升,刘禧,王泓.肝纤维化门静脉压力改变与血清ET-1/NO关系的实验研究[J].生物医学工程与临床,2006,10(6):339-341. 被引量:4
  • 7Rifai K, Cornberg J, Mederacke I, et al. Clinical feasibility of liv- er elastography by acoustic radiation force impulse imaging(AR- FI)[J]. Dig Liver Dis, 2011, 43(6): 491-497.
  • 8Lupsor M, Badea R, Stefanescu H, et aI. Performance of a new el-astographic method (ARFI technology) compared to unidimen- sional transient elastography in the noninvasive assessment of chronic hepatitis C. Preliminary results[J]. J Gastrointestin Liver Dis, 2009, 15(3): 303-310.
  • 9Takahashi H, Ono N, Eguchi Y, et al. Evaluation of acoustic rad- iation force impulse elastography for fibrosis staging of chronic liver disease: a pilot study[J]. Liver Int, 2010, 30(4): 538- 545.
  • 10王兴田,朱巧英,王荣,崔建华,沈培璞,颜学兵.慢性乙型肝炎患者肝剪切波速度与肝纤维化分期的相关性研究[J].中华超声影像学杂志,2011,20(11):953-956. 被引量:8

二级参考文献34

  • 1中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南[J].传染病信息,2005,18(z1):1-12. 被引量:460
  • 2刘东红,吕明德,周才明,徐辉雄.超声衰减成像技术定量评估肝纤维化的临床研究[J].中国医学影像技术,2004,20(8):1231-1233. 被引量:8
  • 3何泽宝,陈智,朱坚胜.卡托普利长期治疗慢性肝炎肝纤维化疗效评估[J].中华传染病杂志,2006,24(2):116-118. 被引量:8
  • 4王晓艳,林礼务,薛恩生,何以敉,高上达.彩色多普勒流速剖面技术对肝硬化程度评价的探讨[J].中国超声医学杂志,2006,22(8):607-610. 被引量:11
  • 5Hanni,Yeshua,Ran Oren.Non invasive assessment of liver fibrosis.Ann Transplant,2008,13(2):5
  • 6Ziol M,Handra-Luca A,Kettaneh A,et al.Noninvasive Assessment of Liver Fibrosis by Measurement of Stiffness in Patients With Chronic Hepatitis C.Hepatology,2005,41(1):48
  • 7Friedman SL,Bansal MB.Reversal ofhepatic fibrosis-fact or fantasy? Hepatology,2006,43(2 Suppl.1):S82
  • 8Don C,Rockey.Noninvasive Assessment of Liver Fibrosis and Portal Hypertension With Transient Elastography.Gastroenterology,2008,134(1):8
  • 9Jules L,John G.American Gastroenterological Association technical review on the management of hepatitis C.Gastroenterology,2006,130(1):231
  • 10Mayo M,Parks J,Huet B,et al.Serum fibrosis markers predict future clinical decompensation in primary biliary cirrhosis better than liver biopsy,bilirubin,or Mayo risk score.Hepatology,2006,44(suppl.1):630

共引文献94

同被引文献37

引证文献3

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部